Axilieva 5mg Tablet: Dual-Mechanism Tyrosine Kinase Inhibition for Advanced Renal Cell Carcinoma Are you searching for a reliable Axilieva 5 mg tablet exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of targeted anti-angiogenic therapies. We maintain an agile and secure supply chain for London (UK), Washington (USA), Canberra (Australia), and South Africa, ensuring that critical oncology medications reach institutional pharmacies with 100% pharmaceutical integrity. Detailed Product Profile: What is Axilieva 5mg? Axilieva 5mg is an oral targeted therapy containing the active pharmaceutical ingredient Axitinib. Manufactured by Allieva Pharma Pvt Ltd, this 5mg tablet is a potent second-generation tyrosine kinase inhibitor (TKI). It is specifically designed to treat advanced kidney cancer by inhibiting the signals that promote tumor growth and the development of supporting blood vessels. 1. Therapeutic Indications Advanced Renal Cell Carcinoma (RCC): Primarily indicated for patients with advanced kidney cancer after the failure of one prior systemic therapy (such as a previous TKI or cytokine treatment). Combination Protocols: Often utilized in advanced clinical settings in combination with immunotherapy agents to improve progression-free survival. Targeted Tumor Control: Effective in slowing the progression of malignant cells that have originated in the kidneys and potentially spread to other organs. 2. Mechanism of Action: Anti-Angiogenesis and Signal Interruption Inhibition of Angiogenesis: It selectively inhibits Vascular Endothelial Growth Factor Receptors (VEGFR-1, VEGFR-2, and VEGFR-3). This effectively “starves“ the tumor by blocking the formation of new blood vessels needed for oxygen and nutrient supply. Disruption of Growth Signaling: By targeting specific receptor tyrosine kinases, it interrupts the abnormal signaling pathways that drive uncontrolled cell proliferation and survival in cancer cells. High Potency: As a second-generation inhibitor, it is designed to be more potent than earlier TKIs, allowing for effective receptor blockade even at lower concentrations. 3. Administration and Dosage Management Standard Dosing: The typical starting dose is 5mg taken twice daily (approximately 12 hours apart). Administration: Can be taken with or without food. Tablets must be swallowed whole with a glass of water and should not be crushed or chewed. Dose Titration: Based on individual patient tolerance and blood pressure response, the dose may be adjusted (increased or decreased) under strict oncological supervision. Clinical Side Effects & Safety Monitoring Hypertension (High Blood Pressure): This is a very common side effect; blood pressure should be well-controlled before starting and monitored frequently during treatment. Gastrointestinal Health: Potential for diarrhea, nausea, and decreased appetite. Maintaining hydration is essential. Thyroid Function: Risk of hypothyroidism; routine monitoring of thyroid-stimulating hormone (TSH) levels is recommended. Bleeding and Wound Healing: Due to its anti-angiogenic nature, it may increase the risk of bleeding or impair wound healing; it is often discontinued before major surgeries. Hand-Foot Syndrome: Monitoring for redness or pain on the palms and soles. Why Source Axilieva 5mg from Ernest Oncology? Verified Authenticity: Direct sourcing of Allieva Pharma’s Axilieva with full batch-specific COA and traceability. Logistics Authority: Expert handling of complex import/export regulations for USA, UK, Australia, and South Africa. Wholesale Solutions: Competitive bulk pricing for hospital groups, specialty pharmacies, and regional distributors. Regulatory Compliance: Every shipment includes GMP certificates and comprehensive B2B documentation to ensure global standards. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383
Washington, USA
08048034998
+919405476170
Chat with us
Chat with us